Match Document Document Title
US20110301033 MICROENCAPSULATED OILS FOR CONTROLLING PESTICIDE SPRAY DRIFT  
Spray drift during the application of agricultural chemicals is reduced by incorporating microencapsulated oils into the aqueous solution or mixture to be sprayed.
US20120115816 COMPATIBILIZED ELECTROLYTE FORMULATIONS  
The invention includes aqueous compatibilized pesticidal formulations and methods of making them. In typical embodiments, formulations comprise a first electrolytic pesticide and a second...
US20120245129 USE OF S1P RECEPTOR MODULATOR  
Use of an S1P receptor modulator in the treatment or prevention of a disease or condirion dependent on brain-derived neurotrophic factor (BDNF) expression.
US20140187516 DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR  
S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
US20120264719 DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR  
S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
US20150182552 COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING PHOSPHOLIPIDS AND ASTAXANTHIN  
A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain....
US20140162964 USE IN BRAIN DEGENERATIVE DISEASES  
Disclosed is a new use for sphingosine-1-phosphate (S1P) receptor agonists in the treatment of progressive dementia or brain degenerative diseases.
US20150004205 BIOMATERIALS HAVING NANOSCALE LAYERS AND COATINGS  
The invention generally relates to surfaces having a protein-resistant hydrogel layer and methods for preparing a protein-resistant hydrogel layer on a surface. The protein-resistant hydrogel...
US20120071446 DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST  
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial 3 to 6 days of treatment the daily dosage is raised so that in total the R-fold (R being...
US20140148415 DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST  
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
US20110257133 DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST  
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
US20130337046 Methods for Improved Delivery of Aminothiols, Dimers of Aminothiols, and Heterodimers Composed of Aminothiols  
The disclosure relates to methods of improving safety, efficacy, or both, of pharmaceutically active aminothiol compounds by delivering them in a thiol-protected form and, preferably intracellularly.
US20120027723 TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION  
The present invention relates to taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration. More particularly the...
US20120277195 PERMEATION ENHANCERS FOR TOPICAL FORMULATIONS  
A composition to be used as a permeation enhancer is provided. The composition may be added to topical cosmetics or pharmaceutical formulations that are topically applied. The composition...
US20120122821 STEROID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS  
Biocompatible intraocular implants include a steroid and an auxiliary agent, where the auxiliary agent is present in an amount sufficient to lessen the severity of at least one side effect...
US20140113883 Therapeutic micro nutrient composition for lipolysis and sclerosis  
An improved formulation and method for the removal of subcutaneous fat deposits in a human in need of such treatment. It also induces an inflammatory reaction which treats disorders of tissue...
US20130195997 FUNGICIDAL MIXTURES  
The invention relates to a method of controlling fungi and spores and to compositions suitable for this purpose and their use. The compositions according to the invention comprise trifloxystrobin,...
US20110034419 Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease  
Disclosed are methods of diagnosing cardiovascular disease comprising measuring sphingolipids. Also disclosed are methods of predicting cardiovascular disease comprising measuring sphingolipids....
US20100317627 Treatment of HCV Disorders  
S1P receptor agonists are useful for the treatment of hepatitis C or chronic hepatitis C (HCV).
US20110190238 MODIFICATIONS OF SOLID 3-SN-PHOSPHOGLYCERIDES  
Methods for hydrolyzing solid ungranulated lysophosphatidylcholine with phospholipase A2 are provided. Also disclosed are methods for making a lipid matrix of lysophosphatidylcholine,...
US20110092466 Method for Protecting Soybeans from Being Infected by Fungi  
Method for protecting soybean plants from being infected by harmful fungi, wherein the soybean plants, their seed or the soil is treated with a fungicidal effective amount of a synergistically...
US20140030366 METHOD FOR TREATING NEURONAL DAMAGE AND NEUROLOGICAL DISEASES  
Disclosed is a method of treating pain. The method includes administering a lecithin as an active ingredient to a mammal to treat the pain, wherein the pain is caused by at least one of herpes...
US20120003158 Biomarkers for Inflammatory Bowel Disease and Methods Using the Same  
The present invention provides various biomarkers of inflammatory bowel disease, including biomarkers for Crohn's disease and biomarkers for Ulcerative colitis. The present invention also provides...
US20090318392 BIOFLUID METABOLITE PROFILING AS A TOOL FOR EARLY PREDICTION OF AUTOIMMUNITY AND TYPE 1 DIABETES RISK  
The invention concerns a method for diagnosing a child's susceptibility for developing type 1 diabetes by using a serum metabolite as biomarker. The invention concerns also a method for prevention...
US20150080347 LIQUID FORMULATIONS  
Disclosed is a concentrate for dilution comprising a S1P receptor agonist or a pharmaceutically acceptable salt thereof, propylene glycol and optionally glycerin. This formulation is adapted for...
US20140179636 LIQUID FORMULATIONS  
Disclosed is a concentrate for dilution comprising a S1P receptor agonist or a pharmaceutically acceptable salt thereof, propylene glycol and optionally glycerin. This formulation is adapted for...
US20120135966 USE OF GLYPHOSATE FOR DISEASE SUPPRESSION AND YIELD ENHANCEMENT IN SOYBEAN  
The present invention discloses methods for prevention and prophylactic treatment of plant diseases by application of glyphosate to a plant in need of treatment. In certain embodiments, soybean...
US20110294874 DIAGNOSIS AND THERAPY OF ORGAN DYSFUNCTION USING SPHINGANINE-1-PHOSPHATE  
The invention relates to the treatment and diagnosis of organ dysfunction caused by ischemia reperfusion injury. In particular, the invention relates to sphinganine-1-phosphate, a sphingolipid...
US20110136739 Use of S1P Receptor Agonists in Heart Diseases  
The invention relates to the use of sphingosine-1-phosphate receptor agonist in the treatment of heart diseases.
US20110053894 Broad Spectrum Antiviral and Methods of Use  
A method for the prevention or treatment of Influenza virus infection or Adenovirus infection by administering an effective amount of a compound of Formula (I), Formula (II), or similar compound...
US20130217647 Biomarkers for Prostate Cancer and Methods Using the Same  
Biomarkers (and suites of biomarkers) relating to prostate cancer are provided, as well as methods for using such biomarkers (ans suites thereof), including early prediction of prostate cancer,...
US20130323318 PROTEIN FREE SURFACTANT COMPOSITION FOR PULMONARY DISEASES AND A PROCESS FOR PREPARING THE SAME  
A protein free surfactant composition comprising dipalmitoylphosphatidyl choline (DPPC) and eugenol having a ratio in the range of 10:5 to 4:2 with >99% airway patency in the presence of albumin,...
US20100069335 Prevention and Treatment of Ophthalmic Complications of Diabetes  
An method and formulation are provided for the prevention and treatment of adverse ocular conditions which are complications of diabetes. In one embodiment, the invention comprises administering...
US20140134270 AGRICULTURAL PESTICIDE COMPOSITIONS  
A composition contains an agricultural pesticide and an incompletely hydrated water soluble polymer suspended in a liquid medium.
US20140193376 COMBINED CHEMICAL MODIFICATION OF SPHINGOSINE-1-PHOSPHATE (S1P) AND CXCR4 SIGNALLING PATHWAYS FOR HEMATOPOIETIC STEM CELL (HSC) MOBILIZATION AND ENGRAFTMENT  
The present embodiments provide for combinations of modulators that increase hematopoietic stem cell engraftment or increase mobilization in vivo. Methods and compositions for modulating the...
US20150030667 COMPOSITIONS AND METHODS FOR TREATING UNDERACTIVE BLADDER  
Methods and compositions for treating underactive bladder and/or symptoms thereof are disclosed, wherein the composition including an effective amount of a therapeutic agent and a pharmaceutically...
US20140370115 LIPID EXTRACTION PROCESSES  
The present invention provides improved processes for extracting and preparing lipids from biological sources for use in pharmaceuticals, nutraceuticals and functional foods.
US20130345177 Oleyl Phosphocholine for the Treatment of Mycosis  
The present invention relates to the use of oleyl phosphocholine (C18:1-PC), or OlPC,for the treatment of mycosis, and especially for the treatment of mycosis such as mycosis caused by pathogens...
US20120195861 METHODS AND COMPOSITIONS FOR PRODUCING GERM CELLS FROM PERIPHERAL BLOOD DERIVED GERMLINE STEM CELLS  
Described herein are the use of peripheral blood derived germline stem cells and their progenitors, methods of isolation thereof, and methods of use thereof.
US20110202033 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY  
Disclosed herein are compositions and methods for the treatment and/or prevention of pathological conditions associated with ischemia/reperfusion injury and/or hypoxic injury of myocardial cell or...
US20130017190 TREATMENT OF INFLAMMATORY DISEASES  
The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the...
US20100310547 Treatment of Inflammatory Diseases  
The present invention relates generally to the field of inflammatory diseases of the peripheral nervous system. More particularly, it concerns methods for treating inflammatory diseases of the...
US20140271541 SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS  
Disclosed are pharmaceutical combinations comprising at least one S1P receptor agonist, as well as a method for treating demyelinating diseases, e.g. multiple sclerosis or disorders associated...
US20110172171 TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION OF BRAIN OEDEMA  
The present invention relates to taurine or taurine-like substances for the prevention of brain oedema, particularly brain intramyelinic oedema and more particularly brain intramyelinic oedema...
US20130143842 STABLE AQUEOUS COMPOSITIONS COMPRISING BIOACTIVE CREATINE SPECIES  
Compositions containing one or more bioactive forms of creatine, which are aqueous compositions in which the one or more bioactive forms of creatine do not appreciably degrade into creatinine....
US20140309113 Pesticide Composition Having Improved Rainfastness  
A pesticide composition includes an active component and polyethyleneimine having a weight average molecular weight of at least about 750,000 g/mol and has improved rainfastness. The...
US20110110984 Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds  
The present invention relates to pharmaceutical solid dosage forms for oral administration comprising a tri-substituted glycerol compound or a pharmaceutically acceptable salt thereof. The...
US20130101514 COMPOSITIONS AND METHODS FOR TREATING NEPHROPATHY  
Activated fatty acids, pharmaceutical composition compositions including activated fatty acids, methods for using activated fatty acids to treat nephropathy, and methods for preparing activated...
US20150184210 METHOD FOR PRODUCING PHOSPHOLIPID-CONTAINING COMPOSITION, AND PHOSPHOLIPID-CONTAINING COMPOSITION  
A method for producing a phospholipid-containing composition which includes 10% by weight or more of phosphatidylserine based on the whole phospholipid-containing composition, a content of a...
US20130156846 L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS  
L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates for treatment, amelioration and/or prevention of protein aggregation/tangles/plaques and diseases associated with...